About Immune checkpoint inhibitor-induced myositis
Immune checkpoint inhibitor-induced myositis is a rare disease catalogued by Orphanet (ORPHA:714829). Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries worldwide.
Clinical Trial Eligibility Tips
What to know before applying to Immune checkpoint inhibitor-induced myositis trials.
Search ClinicalTrials.gov for "Immune checkpoint inhibitor-induced myositis" or Orphanet code ORPHA:714829 to find disease-specific recruiting studies.
Ask your specialist to refer you to an Orphanet-accredited Centre of Expertise for this condition.
Natural history studies and patient registries often open enrolment before drug trials — contact the Orphanet patient community first.
Patient Resources
Find recruiting Immune checkpoint inhibitor-induced myositis trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Immune checkpoint inhibitor-induced myositis. Updated daily.